Related Experiment Videos
Orthotopic liver transplantation in ninety-three patients
Insights
Orthotopic liver transplantation outcomes improved over time. Technical issues and infections, not rejection, were primary causes of death, necessitating better surgical standardization and diagnostic accuracy.
Area of Science:
- Hepatology
- Transplant Surgery
- Gastroenterology
Background:
- Orthotopic liver transplantation (OLT) is a complex procedure for end-stage liver disease.
- Patient outcomes have historically been limited by mortality and complications.
Purpose of the Study:
- To evaluate outcomes and causes of mortality in 93 consecutive orthotopic liver transplant patients over an 11.5-year period.
- To identify factors influencing graft survival and identify areas for improvement in liver transplantation.
Main Methods:
- Retrospective analysis of 93 OLT patients (56 pediatric, 37 adult) undergoing transplantation over 11.5 years.
- Review of indications for surgery, survival rates, causes of late death, and postoperative complications.
Main Results:
- Overall survival improved, with 27 patients surviving at least one year and 16 surviving 13-71 months.
- Late deaths (11) were primarily due to chronic rejection, biliary obstruction, infection, or recurrence of hepatoma.
- Technical complications (biliary reconstruction) and systemic infections were more frequent causes of failure than histologically confirmed rejection.
- Adult recipients experienced a high rate of cerebrovascular accidents postoperatively.
Conclusions:
- While OLT survival has improved, significant challenges remain.
- Reducing operative complications through technical refinement and improved biliary reconstruction is crucial.
- Accurate differential diagnosis of postoperative hepatic dysfunction, utilizing tools like cholangiography and biopsy, is essential for optimizing patient management and improving long-term outcomes.
Abstract:
During the 11 1/2 year period ending 13 months ago, 93 consecutive patients were treated with orthotopic liver transplantation. Fifty-six of the recipients were 18 years old or younger, and the other 37 were adults. The most common indications for operation were biliary atresia, primary hepatic malignant tumor, chronic aggressive hepatitis and alcoholic cirrhosis. There has been a gradual improvement in results throughout the period of study, although to a satisfactory level. Twenty-seven of the 93 patients survived for at least one year after liver replacement with a maximum of six years, and 16 are still alive after 13 to 71 months. The 11 late deaths after one to six years were caused by chronic rejection, biliary obstruction, recurrence of hepatoma, systemic infection or hepatitis of the homograft. Rejection of the liver as judged by classical histopathologic criteria played a surprisingly small role in the heavy over-all mortality, accounting for less than 10 per cent of the deaths. Technical or mechanical problems, especially those of biliary duct reconstruction, were a far greater cause of failure, as were systemic infections. Six of the 37 adult recipients had lethal cerebrovascular accidents during, or just after, operation. When abnormalities of liver function developed in the postoperative period, the nearly automatic diagnosis of homograft rejection, in retrospect, proved to have been wrong in most instances. Further development of liver transplantation depends upon two kinds of progress. There must be reduction of operative and early postoperative accidents and complications by more discriminating patient selection, purely technical improvement and better standardization of biliary duct reconstruction. The second area will be in sharpening the criteria for the differnetial diagnosis of postoperative hepatic malfunction, including the liberal use of transhepatic cholangiography and needle biopsy. Only then can better decisions be made about changes in medication or about the need for secondary corrective surgical procedures.